The Pharmacy Times® Skin Cancer Resource Center is a comprehensive resource for clinical news and expert insights on cancers that occur on the skin, including basal cell carcinoma, squamous cell carcinoma, and melanoma.
April 1st 2024
It is unclear why the vaccines were less effective in women, but researchers note that the findings can be important when determining immune therapy outcomes in patients with melanoma.
December 27th 2023
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Study Results Find Different Mechanisms of Action in 2 Immune Checkpoint Inhibitor Regimens
December 18th 2023The differences between the regimens, anti-PD1/CTLA-4 and anti-PD1/LAG-3, can be used to optimize outcomes for patients with melanoma, particularly in those who develop drug resistance.
Read More
Cancer Diagnoses Significantly Decreased in First Few Months of COVID-19 Pandemic
September 14th 2023Investigators found an approximately 23% decrease in overall cancer incidence in April 2020, specifically for breast, colon, rectal, head and neck cancers, as well as melanoma and endocrine cancer diagnoses.
Read More
Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis
September 13th 2023Experts agreed that it was appropriate for patients who use methamphetamine or cocaine to continue opioid use if clinician monitoring was increased and tapering was avoided.
Read More
FDA Approves Hepzato Kit for Liver-Directed Treatment of Metastatic Uveal Melanoma
August 16th 2023Melphalan/hepatic delivery system (Hepzato Kit; Delcath Systems Inc) is currently the only liver-directed therapy approved by the FDA for the treatment of netastatic uveal melanoma and percutaneous hepatic perfusion.
Read More